- Price is above Fair Value, showing premium demand versus the model.
- Next-week expectancy is positive at 67.67% based on similar historical setup states.
KRKG
VIE
Week ended 07 Aug 2026
Weekly Investor Report
Krka, d. d. · Healthcare · Drug Manufacturers - Specialty & Generic
Latest close
261.0 EUR
0.4%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is - below the Trend Line and sits at 75.5% of its 52-week range. The latest completed week returned 0.4%, after a 2.7% four-week move. The latest news-sentiment score is 50/100.
Setup score
42
out of 100
Latest Close
261.0 EUR
7 Aug 2026
1W Return
0.4%
latest completed week
4W Return
2.7%
short-term follow-through
12W Return
1.0%
quarterly tape
Trend Breadth
0.0%
0 of 23 weeks active
Volume Ratio
-
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Activity pressure is negative, which weakens the current setup.
- Activity pressure is weak, so confirmation is not yet broad enough.
- 4 reversal markers appear in the recent smart-money tape.
- Price is close to its 52-week high; watch for continuation or exhaustion.
- Activity pressure is the gauge to monitor for confirmation or fade.
Price follow-through
0.4%
Latest completed week; four-week move 2.7%.
Indicator stack
0/50
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Positive 67.67%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
50/100
1 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is - below the Trend Line and sits at 75.5% of its 52-week range. The latest completed week returned 0.4%, after a 2.7% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is - the 13-week average. Participation data is incomplete.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.2812-week average 0.18
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.28Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers44 reversal markers
No recent accumulation markers. 4 reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 2.7% over four weeks, 1.0% over 12 weeks, and - over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year0
Trend breadth0.0%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.00Latest activity-pressure read.
Pressure change-Four-week change in activity pressure.
Leadership-Latest relative-leadership reading.
RS change-Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 1 relevant articles.
0 positive · 1 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-4.4%Distance below the 52-week high.
13-week volatility1.7%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
6 Mar
3 Apr
1 May
29 May
26 Jun
24 Jul
7 Aug
Weeks higher15 of 225 weeks finished lower.
Best week+2.9%Week of 8 May.
Worst week-3.4%Week of 26 Jun.
Latest week+0.4%Week of 7 Aug.
Shape of recent returns
Strong gains0
Modest gains15
Flat weeks2
Modest losses5
Sharp losses0
Recent vol1.7%13-week weekly-return volatility.
Base vol1.5%52-week weekly-return volatility.
Up/down split15/5Count of positive and negative weeks in the 52-week window.
Average skew1.4% / -1.6%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorAT Healthcare
4-week rank46 / 100
Group average2.6%
Trend breadth47.0%
Trend47.0%active weekly trend signals
MD73.0%positive activity pressure
RS10.0%positive relative leadership
Four-week leaders
IndustryAT Drug Manufacturers - Specialty & Generic
4-week rank7 / 16
Group average-0.9%
Trend breadth50.0%
Trend50.0%active weekly trend signals
MD12.5%positive activity pressure
RS12.5%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape38/100
Trend, activity pressure, participation, and risk combine to a 38/100 tape read.
Indicator analysis6/100Latest 12-week confirmation: trend 0/12, activity pressure 0/12, relative leadership 0/12.
Activity pressure 0.28; 4 reversal markers Next-Week ExpectancyPositive 67.67%Next-week expectancy is positive with a 67.67% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 1 relevant articles.
€243 - That's What Analysts Think Krka, d. d. (LJSE:KRKG) Is Worth After These Results Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 261.0 EUR | 0.4% | - | 249.2 EUR | 0.00 | - | 0 | Off |
| 31 Jul 2026 | 260.0 EUR | -1.9% | - | 248.7 EUR | 0.00 | - | 0 | Off |
| 24 Jul 2026 | 265.0 EUR | 1.6% | - | 248.2 EUR | 0.00 | - | 0 | Off |
| 17 Jul 2026 | 261.0 EUR | 2.7% | - | 247.3 EUR | 0.00 | - | 0 | Off |
| 10 Jul 2026 | 254.2 EUR | 0.6% | - | 246.6 EUR | 0.00 | - | 0 | Off |
| 3 Jul 2026 | 252.7 EUR | 1.0% | - | 246.2 EUR | 0.00 | - | 0 | Off |
| 26 Jun 2026 | 250.3 EUR | -3.4% | - | 245.8 EUR | 0.00 | - | 0 | Off |
| 19 Jun 2026 | 259.0 EUR | 0.2% | - | 245.5 EUR | 0.00 | - | 0 | Off |
| 12 Jun 2026 | 258.5 EUR | 0.4% | - | 244.6 EUR | 0.00 | - | 0 | Off |
| 5 Jun 2026 | 257.5 EUR | 1.2% | - | 243.6 EUR | 0.00 | - | 20 | Off |
| 29 May 2026 | 254.5 EUR | -1.5% | - | 242.5 EUR | 0.00 | - | 0 | Off |
| 22 May 2026 | 258.5 EUR | 0.0% | - | 241.5 EUR | 0.00 | - | 40 | Off |
| 15 May 2026 | 258.5 EUR | 2.8% | - | 240.0 EUR | 0.00 | - | 0 | Off |
| 8 May 2026 | 251.5 EUR | 2.9% | - | 238.2 EUR | 0.00 | - | 0 | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.